Drug intelligence / Profile preview

Fisiocrem Joint Ease

Development stage
Unknown
Lead developer
Fisiocrem International
Modality
Small Molecules
Administration
Topical
01

Overview

Fisiocrem Joint Ease is a topical over-the-counter analgesic cream/gel developed by Fisiocrem International for the temporary relief of symptoms associated with mild osteoarthritis, mild arthritis, and mild joint pain. The formulation is based on the Fisiocrem Solugel base and is enhanced with additional botanical active ingredients, specifically *Boswellia serrata* sap concentrated resin extract and *Nigella sativa* (black cumin) seed oil. Other key components include menthol, *Arnica montana*, *Calendula officinalis*, *Hypericum perforatum* (St. John's Wort), and *Melaleuca alternifolia* (tea tree) oil. The product works through the combined anti-inflammatory and analgesic properties of these naturally-derived ingredients to reduce joint inflammation and stiffness while promoting mobility. It is designed as a non-greasy, low-odour, non-heat formulation suitable for ongoing joint comfort and is available in various formats including tubes and pump bottles.

Brand names
Fisiocrem Joint Ease
Other names
Joint Ease
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Fisiocrem Joint Ease.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fisiocrem Joint Ease.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call